key: cord-0856879-6hoe00wg authors: Ding, Xiong; Li, Ziyue; Liu, Changchun title: Monolithic, 3D-Printed Lab-on-Disc Platform for Multiplexed Molecular Detection of SARS-CoV-2 date: 2021-10-27 journal: Sens Actuators B Chem DOI: 10.1016/j.snb.2021.130998 sha: 4ba9222a2897974b95863f25ec0dffefb14917ca doc_id: 856879 cord_uid: 6hoe00wg Multiplexed detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rather than detection targeting a single gene is crucial to ensure more accurate coronavirus disease 2019 (COVID-19) diagnostics. Here, we develop a monolithic, 3D-printed, lab-on-disc platform for multiplexed molecular detection of SARS-CoV-2. The centrifugal lab-on-disc is fabricated in one step using simple 3D printing technology, circumventing the need for aligning and binding multiple layers. By combining isothermal amplification technology, this lab-on-disc platform is capable of simultaneously detecting the nucleoprotein and envelope genes of SARS-CoV-2 as well as an internal control of the human POP7 gene. Within a 50-minute incubation period, 100 copies SARS-CoV-2 RNA can be detected through visual detection according to color and fluorescence changes in the disc. Further, we clinically validated the lab-on-disc platform by testing 20 nasopharyngeal swab samples and demonstrated a sensitivity of 100% and an accuracy of 95%. Therefore, the monolithic, 3D-printed, lab-on-disc platform provides simple, rapid, disposable, sensitive, reliable, and multiplexed molecular detection of SARS-CoV-2, holding promise for COVID-19 diagnostics at the point of care. The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed more than 4 million lives all over the world [1] . Although an increasing number of COVID-19 vaccine doses are being administered in many countries, rapid SARS-CoV-2 diagnostics of presymptomatic and asymptomatic COVID-19 patients still plays a vital role in combating the COVID-19 pandemic [2, 3] . Currently, the most commonly used SARS-CoV-2 diagnostics approach is reverse transcription polymerase chain reaction (RT-PCR) [4, 5] . By targeting a single gene or multiple genes, RT-PCR can identify SARS-CoV-2 with high sensitivity and specificity [6, 7] . However, RT-PCR assays depend on expensive thermal cycling instruments, require over 2 hours to complete, and must be conducted by well-trained personnel in central laboratories, and thus are often inaccessible in rural areas and resource-limited settings. As alternatives to RT-PCR assays, reverse transcription isothermal amplification assays such as reverse transcription loop-mediated isothermal amplification (RT-LAMP) [8] , reverse transcription recombinase polymerase amplification (RT-RPA) [9] , and reverse transcription dual-priming mediated isothermal amplification (RT-DAMP) [10] offer advantages of rapid testing, ease of use, low cost, independence of bulky instruments, and visual product detection. To improve the detection accuracy, researchers have begun developing isothermal amplification assays targeting multiple genes of SARS-CoV-2 [11] [12] [13] . However, most of them rely on multiple fluorescence probes and bulky expensive fluorescence detector, which is not ideal for point of care diagnostic application J o u r n a l P r e -p r o o f in resource-limited settings. Therefore, rapid, low-cost, disposable, and multiplexed molecular detection platform of SARS-CoV-2 remains a highly unmet need. To this end, we sought to leverage a lab-on-disc platform, which make it possible to couple centrifugal microfluidic discs and isothermal amplification. Towards point-of-care testing, labon-disc platforms have particular advantages [14, 15] . First, a low-cost spinning motor drives the fluid flow in the discs, avoiding the need for complicated pneumatic interfaces and pumps. Second, centrifugal forces can efficiently remove disturbing bubbles and residual volumes of samples and reagents. Third, multiple chambers can be fabricated to achieve multiplexed assays easily. Current fabrication methods for lab-on-discs typically involve aligning and binding processes for multiple layers, such as soft lithography, hot embossing and injection molding, and micromachining [16] [17] [18] . However, such time-consuming and bulky instrumentation-dependent fabrication approaches challenge the molecular diagnostic applications of lab-on-disc platforms. To this end, the emerging 3D printing technology provides an alternative method to rapidly manufacture complex microfluidic devices for bioassays [19, 20] . With the advancement of inexpensive benchtop 3D printers with high-resolution (down to 25 μm) capabilities, researchers have successfully applied 3D printing technology to pathogen detection, blood separation, electrochemical sensors, cell culture, and more. In this study, we developed a monolithic, 3D-printed, and inexpensive lab-on-disc platform for rapid, multiplexed, molecular detection of SARS-CoV-2. The lab-on-disc platform can simultaneously detect three different genes including the nucleoprotein (N) and envelope (E) genes of SARS-CoV-2 as well as an internal control of the human POP7 gene (POP7). Further, the detection results are visually inspected based on color and fluorescence changes in the discs. Further, we have clinically validated the lab-on-disc platform by testing clinical nasopharyngeal (NP) swab samples. Thus, the 3D-printed lab-on-disc platform provides simple, rapid, disposable, sensitive, reliable, and multiplexed SARS-CoV-2 detection, offering great potential to facilitate COVID-19 diagnostics at the point of care. A high-resolution stereolithographic (SLA) laser-based 3D printer Form 2 from Formlabs was used to print the disc. The material for 3D printing was a clear methacrylate-based resin (Formlabs, FLGPCL02). First, a 3D design drawing of the disc was created using SolidWorks software (Waltham, MA). After uploading the drawing file, the printer began to work at a 50 μm resolution. Upon completion, the printed discs were removed from the build plate in the printer and immersed in isopropanol for 20 min, followed by a 25-min ultrasonic cleaning with acetone. The printed centrifugal lab-on-disc was then thoroughly washed with deionized water and rapidly dried with air. All of the lab-on-discs were stored in a cool, dry place until use. Table S1 . RT-DAMP primers were designed according to principles previously reported by our lab [21] . After incubation, the tubes were placed on a black background or in a Bio-Rad gel imaging system with ultraviolet (UV) light for endpoint visual detection. Before operating, adhesive sealing films (Microseal 'B' Film) were clipped to proper sizes to fully cover the lab-on-disc surfaces. Each primer set was pipetted into every two adjacent chambers. For each chamber, 2.5 μL of 10 × primer mix was added, followed by 7. As shown in Figure 1 , the lab-on-disc platform for rapid, multiplexed detection of SARS-CoV-2 mainly consists of the 3D-printed lab-on-disc, a portable mini centrifuge, and a mini block heater. For implementation, clinical NP swab samples are collected from patients, followed by RNA extraction. A master mix of isothermal amplification reaction is prepared by adding the extracted RNA, and is then applied for multiplexed molecular detection of SARS-CoV-2 via the lab-on-adisc platform. Prior to sealing with adhesive tape, the primer mixes are loaded into the eight chambers. If every two adjacent chambers are filled with the same primer set, the lab-on-disc platform is capable of simultaneously detecting four different target genes. In this study, we have Table S1 . Current centrifugal lab-on-disc platforms are most often fabricated using two strategies, the photolithography method and the non-photolithography method [17] . In the former, polymer materials such as polydimethylsiloxane (PDMS) are used to fabricate the lab-on-discs using photolithography-created molds. In the latter, the lab-on-disc is made through the assembly of multiple layers of polymethyl methacrylate (PMMA) and adhesive polyethylene terephthalate (PET) or PDMS. Although both of these approaches can create discs with multifunction integration, the required steps of aligning and binding multiple layers as well as surface modifications greatly complicate the fabrication [16, 23, 24] . Thus, in this study, we employed a simple SLA-based 3D-printing technology for rapid, one-step, prototyping of lab-on-disc systems with high resolution, optical transparency, and minimized roughness. (Figure 2B ). After filling with red dyes, vertical 3D structures are clearly evident in the disc. The lab-on-disc is fabricated in one step by a 3D printer, avoiding the aligning and binding processes of multiple layers. This rapid prototyping procedure is beneficial for largescale and low-cost production of lab-on-disc systems, enabling fast deployment for scaled COVID-19 diagnostics. Prior to testing in the lab-on-disc platform, we developed a tube-based visual isothermal amplification approach for SARS-CoV-2 detection by targeting different genes. As shown in (Figure 3B and S1), we selected the primer sets of N-1, N-2, and E for the subsequent development of our lab-on-disc system. By testing various copies of SARS-CoV-2 RNA, we demonstrated that visual RT-DAMP assays with N-1, N-2, and E primer sets can detect 5, 500, and 500 copies RNA within 50 min, respectively, showing high detection sensitivities ( Figure 3C) . Further, we designed an additional primer set targeting the human POP7 gene as an internal control for SARS-CoV-2 detection for the RT-DAMP assay. As shown in Figure S2 , the assay with the internal control is also highly sensitive, as it can detect 500 copies of the POP7 gene sequence. Accordingly, we employed the N-1, N-2, E, and POP7 primer sets to establish the lab-on-disc assay. Experiments were repeated for three times. Calcein-MnCl 2 dye was used to achieve visual detection and the incubation time was 50 min. NTC, non-template control reaction. Error bars represent the means ± standard deviations from three replicates. To combat the ongoing COVID-19 pandemic, a rapid, low-cost, disposable, and multiplexed system for SARS-CoV-2 detection is needed. Previously reported strategies primarily involve multiple fluorescence probes and large detection instruments, which are not appropriate for point-of-care testing [6, 7, [11] [12] [13] . Alternatively, microfluidic chip-based multiple molecular J o u r n a l P r e -p r o o f detection systems are more advantageous, due to simplicity and low cost [25, 26] . Here, we developed a monolithic, 3D-printed lab-on-disc platform for rapid, multiplexed molecular detection of SARS-CoV-2. In this platform, the microfluidic discs are fabricated in one step and the centrifugal forces enable fast reagent loading without need for time-consuming pipetting operation. As shown in Figure 4A , we pre-filled every two adjacent chambers with one primer set in the disc, thereby simultaneously detecting four different targets (N-1, N-2, E, and POP7) . After loading the RT-DAMP master mix with extracted RNA from SARS-CoV-2-positive samples, we incubated the disc at 63 °C for 50 min on a mini heat block. Under UV and natural light, positive chambers indicate strong fluorescence and green color, providing visual multiplexed SARS-CoV-2 detection. Due to the vertical structural design plus light oil sealing, each chamber in the disc is completely isolated without causing reagent coalescence ( Figure S3) . Further, we demonstrated that the lab-on-disc platform is specific to SARS-CoV-2 RNA and has no crossreactivity towards the N gene or human RNA extract of Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) [27] (Figure 4B) . However, the platform has a crossreactivity with the N gene of SARS-CoV, another fatal coronavirus from 2003 [28] . Through aligning the N gene sequences of MERS-CoV, SARS-CoV, SARS-CoV-2, and four other common human coronaviruses (hCoV-OC43, hCoV-HKU1, hCoV-NL63, and hCoV-229E [29] ), we found that SARS-CoV-2 has high genetic homology with SARS-CoV with only few single nucleotide polymorphisms (SNPs) in the corresponding primer sites for the N-1 and N-2 primer sets ( Figure S4 and S5) . Similar to RT-LAMP, using RT-DAMP with nonspecific dyes such as EvaGreen, calcein, and pH indicators is difficult to differentiate targets with few SNPs, unless coupling with mismatch-suppression enzymes or specially designed probes [30] [31] [32] [33] . Thus, the specificity of the current lab-on-disc platform would be further improved by using SNP-specific probes. However, although SARS-CoV is also a fatal virus [34] , there have not been any known SARS-CoV cases reported globally since 2004. By testing various copies of a commercial SARS-CoV-2 RNA control, we investigated the lab-on-disc platform's sensitivity. As shown in Figure 4C , within 50 min, the platform is able to detect 100 copies of SARS-CoV-2 RNA, showing high sensitivity. Thus, the lab-on-disc platform is specific and highly sensitive at detecting SARS-CoV-2. We conducted clinical validation of the lab-on-disc platform by testing 20 de-identified clinical NP swab samples and extracting their RNA by using commercial RNA extraction kits. Figure 5A shows the workflow of lab-on-disc assay for clinical sample testing. The entire procedure can J o u r n a l P r e -p r o o f be completed in about 70 min from sample to answer. In the future, this test time could be further narrowed by interfacing the lab-on-disc platform with extraction-free detection strategies [35] . We confirmed that the 20 clinical samples included 10 SARS-CoV-2-positive and 10 SARS-CoV-2-negative samples by using CDC-released RT-qPCR assays. As shown in Figure 5B , the positive Cq values ranged from 17.4 to 39.1. By testing the same samples, our lab-on-disc-based multiplexed SARS-CoV-2 detection approach presented with similar results, with the exception of S15 (Figure 5B and S6) . Based on the lab-on-a-disc detection, S15 is positive, as the N-1, E, J o u r n a l P r e -p r o o f and POP7 genes all produced positive results. The inconsistency between the assays may be attributed to RNA damage happening in the amplification region during sample preparation in the RT-qPCR assay. The results of the lab-on-disc platform are displayed in Figure 5C . The POP7 internal control testing is important to classify the true negative and the quality control (QC) failures. If at least one of the three target genes of N-1, N-2, and E presents with positive signals, the result should be considered SARS-CoV-2 positive. Towards point-of-care diagnostics, we note that this lab-on-disc testing approach serves as a preliminary screening, especially for samples indicating positive values for only one target gene. Taking the RT-qPCR results as the standard, the confusion matrix indicates that our lab-on-disc platform has 100% sensitivity, 90% specificity, and 95% accuracy ( Figure 5D) . Therefore, our monolithic, 3Dprinted lab-on-disc platform is sensitive and reliable for COVID-19 diagnostics at the point of care. In conclusion, we developed a monolithic, 3D-printed lab-on-disc platform for rapid, visual, multiplexed molecular detection of SARS-CoV-2. Unlike previously reported lab-on-disc systems [14, 15] , our disc is fabricated in one step by 3D printing, eliminating the aligning and binding processes needed for multiple layers. Our lab-on-disc platform is able to simultaneously detect three different SARS-CoV-2 gene regions and one internal control gene region, enabling sensitive, reliable, and multiplexed molecular diagnostics. If needed, more reaction chambers can be integrated into single lab-on-disc platform for high-throughput detection screening of COVID-19. Within a 50-min incubation period, the lab-on-disc system has a high sensitivity (100 copies per chip) and high specificity (no cross-reactivity). Further, we clinically validated the lab-on-disc platform by testing 20 NP swab samples. Compared to the TaqMan probe-based RT-qPCR assays, our lab-on-disc platform demonstrated a sensitivity of 100% and an accuracy of 95%. Therefore, towards point-of-care diagnostics, our lab-on-disc platform provides simple, rapid, disposable, sensitive, reliable, and multiplexed SARS-CoV-2 detection and allows for preliminary screening for rapid COVID-19 diagnostics. In addition, by replacing the primers and targets, our platform could be easily applied to detect other infectious diseases, such as the influenza A virus, human immunodeficiency virus (HIV), and Zika virus. These advantages notwithstanding, our platform can be further improved in terms of sample preparation and J o u r n a l P r e -p r o o f throughput in the future. For example, through integrating on-chip nucleic acid extraction unit, we can develop a fully integrated, "sample-in-answer-out", lab-on-disc detection system. The authors declare no other competing interests. COVID-19) Dashboard Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19 Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic Positive RT-PCR test results in patients recovered from COVID-19 Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay An enhanced isothermal amplification assay for viral detection Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay Development of multiplexed reverse-transcription loop-mediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) assay for on-site diagnosis of SARS CoV-2 Sequence-specific and multiplex detection of COVID-19 virus (SARS-CoV-2) using proofreading enzyme-mediated probe cleavage coupled with isothermal amplification A review of biomedical centrifugal microfluidic platforms, Micromachines Centrifugal microfluidic platforms: advanced unit operations and applications A microdevice for rapid, monoplex and colorimetric detection of foodborne pathogens using a centrifugal microfluidic platform A review of centrifugal microfluidics in environmental monitoring Biosensing on the centrifugal microfluidic lab-ona-disc platform Analytical chemistry enabled by 3D printing: Sensors and biosensors 3D printed microfluidics for biological applications Dual-Priming isothermal amplification (DAMP) for highly sensitive and specific molecular detection with ultralow nonspecific signals CDC, CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel Microstructuring of polymer films for sensitive genotyping by real-time PCR on a centrifugal microfluidic platform Hand-powered centrifugal microfluidic platform inspired by the spinning top for sample-to-answer diagnostics of nucleic acids Multiplexed colorimetric detection of SARS-CoV-2 and other pathogens in wastewater on a 3D printed integrated microfluidic chip Autonomous lab-on-paper for multiplexed, CRISPR-based diagnostics of SARS-CoV-2 Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group Lung pathology of fatal severe acute respiratory syndrome Human Coronavirus-229E,-OC43,-NL63, and-HKU1 (Coronaviridae), Encyclopedia of Virology Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology Loop-primer endonuclease cleavage-loop-mediated isothermal amplification technology for multiplex pathogen detection and single-nucleotide polymorphism identification Allele-specific isothermal amplification method using unmodified selfstabilizing competitive primers Visual detection of single-nucleotide polymorphisms using molecular beacon loop-mediated isothermal amplification with centrifuge-free DNA extraction Severe acute respiratory syndrome Rapid and extraction-free detection of SARS-CoV-2 from saliva by colorimetric reverse This work was supported, in part, by the National Institutes of Health, United States (R01EB023607, R61AI154642, and R01CA214072).